187 related articles for article (PubMed ID: 16938710)
1. Infliximab in ulcerative colitis.
Böcker U
Scand J Gastroenterol; 2006 Sep; 41(9):997-1000. PubMed ID: 16938710
[No Abstract] [Full Text] [Related]
2. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.
Hassan C; Zullo A; Ierardi E; Burattini O; De Francesco V; Morini S
Gut; 2006 Apr; 55(4):589-90. PubMed ID: 16531548
[No Abstract] [Full Text] [Related]
3. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.
Arijs I; Li K; Toedter G; Quintens R; Van Lommel L; Van Steen K; Leemans P; De Hertogh G; Lemaire K; Ferrante M; Schnitzler F; Thorrez L; Ma K; Song XY; Marano C; Van Assche G; Vermeire S; Geboes K; Schuit F; Baribaud F; Rutgeerts P
Gut; 2009 Dec; 58(12):1612-9. PubMed ID: 19700435
[TBL] [Abstract][Full Text] [Related]
4. Infliximab in ulcerative colitis.
Aberra FN; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
Fratila OC; Craciun C
J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor necrosis factor therapy for ulcerative colitis.
Kountouras J; Zavos C; Chatzopoulos D
Gastroenterology; 2005 Sep; 129(3):1138-9. PubMed ID: 16143158
[No Abstract] [Full Text] [Related]
7. The use of the anti-tumour necrosis factor monoclonal antibody--infliximab--to treat ulcerative colitis: implications and trends beyond the available data.
Rossetti S; Actis GC; Fadda M; Rizzetto M; Palmo A
Dig Liver Dis; 2004 Jun; 36(6):426-31. PubMed ID: 15248385
[TBL] [Abstract][Full Text] [Related]
8. Infliximab for ulcerative colitis following liver transplantation.
Lal S; Steinhart AH
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):277-80. PubMed ID: 17301656
[TBL] [Abstract][Full Text] [Related]
9. Infliximab for ulcerative colitis.
Simmons J; Jewell DP
Dig Liver Dis; 2002 Sep; 34(9):616-8. PubMed ID: 12405245
[No Abstract] [Full Text] [Related]
10. Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.
Gustavsson A; Järnerot G; Hertervig E; Friis-Liby I; Blomquist L; Karlén P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Magnuson A; Halfvarson J; Tysk C
Aliment Pharmacol Ther; 2010 Oct; 32(8):984-9. PubMed ID: 20937043
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab.
Hassan C; Ierardi E; Burattini O; De Francesco V; Zullo A; Stoppino G; Panella C; Morini S
Dig Liver Dis; 2007 Sep; 39(9):811-7. PubMed ID: 17652038
[TBL] [Abstract][Full Text] [Related]
12. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
13. Induction of manic switch by the tumour necrosis factor-alpha antagonist infliximab.
Elisa B; Beny L
Psychiatry Clin Neurosci; 2010 Aug; 64(4):442-3. PubMed ID: 20653912
[No Abstract] [Full Text] [Related]
14. Infliximab avoiding colectomy and maintaining remission in pediatric immunosuppressive-naïve ulcerative colitis achieving remarkable mucosal healing.
Sciaudone G; Pellino G; Guadagni I; Selvaggi F
Panminerva Med; 2010 Mar; 52(1):91-2. PubMed ID: 20228729
[No Abstract] [Full Text] [Related]
15. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
Jakobovits SL; Jewell DP; Travis SP
Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
[TBL] [Abstract][Full Text] [Related]
16. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
Mocciaro F; Orlando A; Scimeca D; Cottone M
Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
[TBL] [Abstract][Full Text] [Related]
17. Safety of infliximab in patients suffering from inflammatory bowel disease.
Felley C; Michetti P
Digestion; 2004; 70(1):1-2. PubMed ID: 15297772
[No Abstract] [Full Text] [Related]
18. Infliximab for refractory ulcerative proctitis.
Bouguen G; Roblin X; Bourreille A; Feier L; Filippi J; Nancey S; Bretagne JF; Flourié B; Hébuterne X; Bigard MA; Siproudhis L; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2010 Jun; 31(11):1178-85. PubMed ID: 20222911
[TBL] [Abstract][Full Text] [Related]
19. Infliximab or cyclosporine for severe ulcerative colitis.
Hanauer SB
Gastroenterology; 2005 Oct; 129(4):1358-9; author reply 1359. PubMed ID: 16230092
[No Abstract] [Full Text] [Related]
20. Infliximab in refractory severe ulcerative colitis: a case report.
Bossa F; Caserta L; Selvaggi F; Riegler G
Minerva Gastroenterol Dietol; 2005 Sep; 51(3):261-2. PubMed ID: 16280968
[No Abstract] [Full Text] [Related]
[Next] [New Search]
